Group One Trading
AUPH icon

Group One Trading’s Aurinia Pharmaceuticals AUPH Stock Holding History

Group One Trading’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Sell
100,300
-290,600
-74% -$4.25M ﹤0.01% 2354
2025
Q4 		$6.23M Buy
390,900
+50,200
+15% +$712K 0.01% 1293
2025
Q3 		$3.76M Buy
340,700
+40,000
+13% +$437K 0.01% 1745
2025
Q2 		$2.55M Sell
300,700
-159,900
-35% -$1.28M 0.01% 1901
2025
Q1 		$3.7M Buy
460,600
+88,600
+24% +$718K 0.01% 1310
2024
Q4 		$3.34M Sell
372,000
-150,700
-29% -$1.23M 0.01% 1468
2024
Q3 		$3.83M Sell
522,700
-14,900
-3% -$92.4K 0.01% 1214
2024
Q2 		$3.07M Buy
537,600
+72,000
+15% +$379K 0.01% 1116
2024
Q1 		$2.33M Sell
465,600
-414,700
-47% -$2.81M 0.01% 1376
2023
Q4 		$7.91M Buy
880,300
+226,100
+35% +$1.86M 0.02% 829
2023
Q3 		$5.08M Sell
654,200
-269,000
-29% -$2.63M 0.02% 933
2023
Q2 		$8.94M Buy
923,200
+194,700
+27% +$2.02M 0.03% 570
2023
Q1 		$7.98M Buy
728,500
+75,300
+12% +$663K 0.03% 596
2022
Q4 		$2.82M Buy
653,200
+35,600
+6% +$207K 0.01% 1540
2022
Q3 		$4.64M Buy
617,600
+240,000
+64% +$2.08M 0.01% 1217
2022
Q2 		$3.79M Sell
377,600
-232,100
-38% -$2.59M 0.01% 1508
2022
Q1 		$7.55M Sell
609,700
-572,300
-48% -$8.85M 0.01% 1205
2021
Q4 		$27M Buy
1,182,000
+548,400
+87% +$13M 0.02% 535
2021
Q3 		$14M Buy
633,600
+423,400
+201% +$6.72M 0.02% 830
2021
Q2 		$2.72M Buy
210,200
+23,000
+12% +$293K ﹤0.01% 2319
2021
Q1 		$2.43M Sell
187,200
-180,900
-49% -$2.62M ﹤0.01% 2253
2020
Q4 		$5.09M Buy
368,100
+144,700
+65% +$2.11M 0.01% 1265
2020
Q3 		$3.29M Buy
223,400
+38,500
+21% +$558K 0.01% 1204
2020
Q2 		$3M Sell
184,900
-121,600
-40% -$1.95M 0.01% 1173
2020
Q1 		$4.45M Sell
306,500
-109,500
-26% -$1.93M 0.04% 593
2019
Q4 		$8.43M Buy
416,000
+290,600
+232% +$2.68M 0.06% 421
2019
Q3 		$670K Buy
125,400
+83,900
+202% +$508K 0.01% 2087
2019
Q2 		$273K Sell
41,500
-6,500
-14% -$41.4K ﹤0.01% 2620
2019
Q1 		$312K Buy
48,000
+39,300
+452% +$261K ﹤0.01% 2349
2018
Q4 		$59K Sell
8,700
-90,800
-91% -$524K ﹤0.01% 3461
2018
Q3 		$661K Sell
99,500
-2,400
-2% -$13.5K 0.01% 2036
2018
Q2 		$574K Buy
101,900
+58,200
+133% +$325K ﹤0.01% 2184
2018
Q1 		$227K Sell
43,700
-76,800
-64% -$411K ﹤0.01% 2690
2017
Q4 		$546K Buy
120,500
+113,500
+1,621% +$630K ﹤0.01% 2181
2017
Q3 		$44K Sell
7,000
-40,000
-85% -$252K ﹤0.01% 3701
2017
Q2 		$288K Sell
47,000
-223,600
-83% -$1.51M ﹤0.01% 2374
2017
Q1 		$1.99M Buy
270,600
+170,800
+171% +$789K 0.02% 872
2016
Q4 		$210K Buy
+99,800
New +$321K ﹤0.01% 2393

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Group One Trading's AUPH Position: Q1 2026 in Review

Group One Trading opened a new position in Aurinia Pharmaceuticals (AUPH) in Q1 2026: 19,219 shares worth $285K. The stake represents ﹤0.01% of the portfolio and ranks #3849 among its holdings. This is a return to the name: Group One Trading previously reported a position in AUPH as recently as Q2 2025.

Group One Trading first reported a position in AUPH in Q1 2017 and has held it in 34 quarters since. The position peaked at $6.1M in Q4 2023. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Group One Trading held 19,219 shares of Aurinia Pharmaceuticals worth $285K as of Q1 2026.
  • Aurinia Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3849 holding.
  • Group One Trading first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 34 quarters since.
  • Group One Trading's Aurinia Pharmaceuticals position peaked at $6.1M in Q4 2023.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.